$57.60 $1.92 per serving
Product analysis
Brain Cell Support combines ingredients with limited evidence for selected attention and memory benefits after repeated use. The findings depend on the preparation and the people studied, so dependable everyday improvements are uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality33
The available details do not establish a clear advantage in ingredient quality. Some forms and extract proportions are not fully specified, limiting close comparisons with other preparations.
Ingredient Transparency70
All ingredient amounts are listed, which helps you compare servings. Some form details and extract component proportions are missing.
Value For Money26
Acetyl L-carnitine and deanol are costly at the full serving price. Value for the other ingredients remains uncertain because the available comparisons are incomplete.
Customer Satisfaction79
Customer ratings indicate very high satisfaction. Several hundred customer ratings provide a useful picture of satisfaction.
Product Focus63
The ingredients share a clear interest in memory and concentration. Evidence for immediate focus or reliable productivity gains in healthy adults remains limited.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $1.92
- Customer rating
- 4.8 · 527 ratings
Goals
Impact
High effect
Acetyl L-Carnitine · 500 mg
Impact
High effect
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
High effect
Acetyl L-Carnitine · 500 mg
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
High effect
Acetyl L-Carnitine · 500 mgAcetyl L-Carnitine · 500 mg
Impact
Moderate effect
Impact
Moderate effect
Acetyl L-Carnitine · 500 mg
Impact
Lower effect
Acetyl L-Carnitine · 500 mg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Acetyl L-Carnitine | 500 mg | |
Cognizin (Cytidine 5-Diphosphocholine) | 200 mg | |
DMAE | 100 mg | |
Phosphatidylserine (Sunflower) | 100 mg | |
Ginkgo Biloba leaf extract (Ginkgoflavonglycosides, Terpene Lactones) | 120 mg | |
Gotu Kola herb extract (Asiaticoside, triterpenes) | 100 mg |
Acetyl L-Carnitine · 500 mg OverallScore78
The serving provides 500 mg of acetyl L-carnitine HCl, with a very high cost for the amount supplied. The amount falls within the stated range for cognitive and metabolic support. The HCl form is specified. A manufacturing or purity claim is present, though its details are unspecified.
How this ingredient is rated
Active Ingredient Quality & Bioavailability94
The carnitine is acetyl L-carnitine HCl. The salt is specified. A manufacturing or purity claim is present, though its details are unspecified.
ALCAR vs. Standard Carnitine Form
The carnitine is acetyl L-carnitine, the form considered for cognitive support.
Advanced Sourcing and Salt Specificity
The form is acetyl L-carnitine HCl. A manufacturing or purity claim is present, though its details are unspecified.
Dose, Safety & Label Transparency100
The amount is clearly stated at 500 mg per serving, an amount within the stated range for cognitive and metabolic support.
Clinical Dosage Efficacy
The serving provides 500 mg, an amount within the stated range for cognitive and metabolic support.
Label Transparency and Proprietary Blends
The acetyl L-carnitine amount is stated separately.
Value0
The cost is very high for the amount of acetyl L-carnitine supplied.
Price per 500mg Acetyl L-Carnitine
The cost is very high for the amount of acetyl L-carnitine supplied. The estimate uses the full serving price.
Ginkgo (Ginkgoflavonglycosides, Terpene Lactones) · 120 mg OverallScore85
120 mg of ginkgo leaf extract is stated per serving, but its value is not assessed. The extract lists 24% flavones and 6% terpenes. The ginkgolic acid level is unknown.
How this ingredient is rated
Composition and Label Disclosure70
The extract lists 24% flavones and 6% terpenes. The ginkgolic acid level is unknown.
Marker and Preparation Disclosure
The extract lists 24% flavones and 6% terpenes.
Declared Ginkgolic Acid Limit
The ginkgolic acid level is unknown.
Composition and Label Disclosure100
The amount and source are stated: 120 mg of ginkgo leaf extract.
Individual Preparation Amount Disclosure
The amount and source are stated: 120 mg of ginkgo leaf extract.
Commercial Price and Usability
Value was not assessed.
Deanol · 100 mg OverallScore82
Brain Cell Support supplies 100 mg of active DMAE per serving, at a high cost relative to its DMAE content. It names DMAE bitartrate. The proportions of the listed constituents are unclear. The label includes a DMAE-specific warning.
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
DMAE bitartrate is listed, and the active DMAE amount is stated. The proportions of the listed constituents are unclear.
Deanol Form Specificity
The listed form is DMAE bitartrate. The proportions of the listed constituents are unclear.
Active Deanol Yield Transparency
The active DMAE amount is stated as 100 mg per serving.
Dose, Safety & Label Transparency100
The serving provides 100 mg of active DMAE, within the range described for cognitive support. The label includes a DMAE-specific warning.
Dosage Appropriateness
100 mg of active DMAE per serving is within the range described for cognitive support.
Specific Safety Warnings
The label includes a DMAE-specific warning.
Value10
The serving cost is high relative to the active DMAE it provides.
Price Per 100mg Active Deanol
The serving cost is high relative to the active DMAE it provides.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
- Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
- Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
- Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
- Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
- Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
- Senile dementia: treatment with deanol.
- Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
- The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.